Product NDC: | 68820-105 |
Proprietary Name: | Venlafaxine Hydrochloride |
Non Proprietary Name: | Venlafaxine Hydrochloride |
Active Ingredient(s): | 37.5 mg/1 & nbsp; Venlafaxine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68820-105 |
Labeler Name: | Orchid Healthcare (a division of Orchid Chemicals & Pharmaceuticals Ltd.) |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091123 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120707 |
Package NDC: | 68820-105-39 |
Package Description: | 15 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68820-105-39) |
NDC Code | 68820-105-39 |
Proprietary Name | Venlafaxine Hydrochloride |
Package Description | 15 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68820-105-39) |
Product NDC | 68820-105 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Venlafaxine Hydrochloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20120707 |
Marketing Category Name | ANDA |
Labeler Name | Orchid Healthcare (a division of Orchid Chemicals & Pharmaceuticals Ltd.) |
Substance Name | VENLAFAXINE HYDROCHLORIDE |
Strength Number | 37.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |